NCT03259711View on ClinicalTrials.gov

Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase

CompletedOBSERVATIONAL
Enrollment

20,000

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

August 14, 2017

Study Completion Date

August 14, 2017

Conditions
Cardiac Affections
Interventions
DRUG

Hormonal therapies L02 in the ATC classification

Hormonal therapies L02 in the ATC classification

Trial Locations (1)

Unknown

Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03259711 - Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase | Biotech Hunter | Biotech Hunter